Login
Home / 003220.KS : KSC
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Daewon Pharmaceutical Co., Ltd.

₩8000 -$4000.00 (-33.33%)
KSC · 15 Sep 2026 06:30 UTC
Previous Close
₩8020
Day Range
₩7950₩8090
Year Range
₩7060₩13670
Market Cap
171.47B
AVG Volume
109.73K
Trailing/Forward PE
65.26/9.71
PEG ratio
1.03
Dividend Yield
3.12%
Next Earnings Date
-
Primary Exchange
Korea ExchangeKR
Revenue (KRW)
050B100B150B200B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Net Income (KRW)
-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Operating Income (KRW)
-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EBITDA (KRW)
-100B-50B050B100B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash Flows (KRW)
-30B-20B-10B010B20B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
EPS (KRW)
-1000-5000500100024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Expenses (KRW)
020B40B60B80BR&DSG&ACapex24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Cash & Debt (KRW)
0100B200B300BCashLong Term DebtShort Term Debt24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Debt ratios
-4-2024624 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Margins
0%20%40%60%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Return on Capital
-10%-5%0%5%24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Shares Outstanding
010M20M30M24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Dividends (KRW)
0100200300400Dec 16Dec 17Dec 18Dec 19Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25
Book Value Per Share (KRW)
05000100001500024 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
Total Assets (KRW)
0200B400B600B800B24 Q124 Q224 Q324 Q425 Q125 Q225 Q325 Q426 Q126 Q2
PE Ratio
10203040med 20.12Apr 24Jul 24Nov 24Feb 25May 25Sep 25Dec 25
Free Cash Flow Yield
-5%0%5%10%med 4.56%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.20.30.40.50.6med 0.47Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
2.557.51012.515med 8.71Oct 24Jan 25May 25Aug 25Nov 25Mar 26Jun 26
Price/Operating Cashflow
24681012med 6.37Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
0.40.60.811.2med 1Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Daewon Pharmaceutical Co., Ltd.
003220.KS
Stockpicker

Video analysis: 003220.KS

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.